Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse

被引:47
作者
Chen, Q [1 ]
Nakajima, A [1 ]
Meacham, C [1 ]
Tang, YP [1 ]
机构
[1] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA
关键词
behaviors; transgenic mouse;
D O I
10.1073/pnas.0505407103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cholecystokinin (CCK), one of the most abundant neuropeptides in the brain, plays an important role in anxiogenesis through the activation of CCK receptor-2 (CCKR-2). Accumulating evidence, however, has suggested this role depends on endogenous CCKergic "tone," which is largely determined by the expression level of the CCKR-2. Using the tTA/tetO-inducible transgenic (tg) approach, we show here that overexpression of the CCKR-2 in neurons of the forebrain significantly increases CCKR-2 binding capacity in tg mice compared with their littermate controls. Interestingly, these tg mice consistently exhibit increased fear responses, which are generally interpreted as anxiety-like behaviors in the rodent, in a battery of behavioral tests, which represented conflict situations or delivered stress to the subjects. The inhibition of transgene expression with doxycycline treatment completely diminished both increased receptor-binding activity and all behavioral phenotypes. Furthermore, treatment of tg mice with diazepam significantly attenuated these anxiety-like behaviors. Our results directly demonstrate that the elevated CCKergic tone via overexpression of the CCKR-2 in the brain may constitute an underlying molecular/neuronal mechanism for the expression of anxiety. In addition, our study has validated a robust genetic anxiety model in the mouse in terms of their face, constructive, and predictive validity.
引用
收藏
页码:3881 / 3886
页数:6
相关论文
共 61 条
[1]   A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A CCK-B RECEPTOR ANTAGONIST, CI-988, IN PATIENTS WITH GENERALIZED ANXIETY DISORDER [J].
ADAMS, JB ;
PYKE, RE ;
COSTA, J ;
CUTLER, NR ;
SCHWEIZER, E ;
WILCOX, CS ;
WISSELINK, PG ;
GREINER, M ;
PIERCE, MW ;
PANDE, AC .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (06) :428-434
[2]   SSRIs versus non-SSRIs in post-traumatic stress disorder - An update with recommendations [J].
Asnis, GM ;
Kohn, SR ;
Henderson, M ;
Brown, NL .
DRUGS, 2004, 64 (04) :383-404
[3]   Anxiety and panic: from human studies to animal research and back [J].
Battaglia, M ;
Ogliari, A .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (01) :169-179
[4]   DISTRIBUTION OF CHOLECYSTOKININ (CCK) IN THE RAT LOWER BRAIN-STEM NUCLEI [J].
BEINFELD, MC ;
PALKOVITS, M .
BRAIN RESEARCH, 1982, 238 (01) :260-265
[5]   ASYMMETRY IN BEHAVIORAL-RESPONSES TO CHOLECYSTOKININ MICROINJECTED INTO RAT NUCLEUS-ACCUMBENS AND AMYGDALA [J].
BELCHEVA, I ;
BELCHEVA, S ;
PETKOV, VV ;
PETKOV, VD .
NEUROPHARMACOLOGY, 1994, 33 (08) :995-1002
[6]   BENZODIAZEPINES ANTAGONIZE CHOLECYSTOKININ-INDUCED ACTIVATION OF RAT HIPPOCAMPAL-NEURONS [J].
BRADWEJN, J ;
DEMONTIGNY, C .
NATURE, 1984, 312 (5992) :363-364
[7]  
BRADWEJN J, 1991, ARCH GEN PSYCHIAT, V48, P603
[8]   THE CHOLECYSTOKININ HYPOTHESIS OF ANXIETY AND PANIC DISORDER [J].
BRADWEJN, J ;
KOSZYCKI, D .
CHOLECYSTOKININ, 1994, 713 :273-282
[9]   FAILURE OF CCK RECEPTOR LIGANDS TO MODIFY ANXIETY-RELATED BEHAVIORAL SUPPRESSION IN AN OPERANT CONFLICT PARADIGM IN RATS [J].
CHARRIER, D ;
DANGOUMAU, L ;
PUECH, AJ ;
HAMON, M ;
THIEBOT, MH .
PSYCHOPHARMACOLOGY, 1995, 121 (01) :127-134
[10]  
Cohen H, 1999, DEPRESS ANXIETY, V10, P8, DOI 10.1002/(SICI)1520-6394(1999)10:1<8::AID-DA2>3.0.CO